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Abstract
BACKGROUND: Immune system and inflammatory response play an essential role in the development of secondary 
brain injury (SBI) after traumatic brain injury (TBI). An inflammatory biomarker that can reflect the SBI severity is 
needed to increase the effectivity of TBI management and prevent morbidity and mortality post-TBI. Neutrophil-to-
lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), which are more affordable than C-reactive protein 
(CRP) and erythrocyte sedimentation rate (ESR), theoretically have the potential to be used as a marker of the SBI 
severity. However, NLR and PLR in daily medical practice are not yet fully utilized.
AIM: The aim of the study was to correlate NLR and PLR with CRP and ESR as a marker of SBI severity post-TBI.
METHODS: This cross-sectional study was conducted at Sanglah Hospital Denpasar from January to April 2020. 
Patients diagnosed with TBI were included in this study by consecutive sampling. The blood samples were taken 
at 24-h post-TBI to obtain the NLR, PLR, CRP, and ESR results. Spearman’s correlation test was conducted to 
determine the correlation between NLR and PLR with CRP and ESR.
RESULTS: Eighty-five patients were included in data analysis. Median ± (interquartile range) of the NLR, PLR, CRP, 
and ESR were 7.60 ± (6.83), 145.58 ± (76.95), 60.83 ± (66.3), and 12.50 ± (13.85) consecutively. NLR and PLR had 
a significant positive correlation with CRP (r = 0.472, **p < 0.01; r = 0.283, **p < 0.01 consecutively). But, NLR and 
PLR were not correlated with ESR.
CONCLUSION: NLR and PLR can become a useful and more affordable marker for reflecting the SBI severity in 
acute TBI.
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Introduction
Traumatic brain injury (TBI) is a type of 
injury that becomes one of the leading causes of 
global morbidity, mortality, and socio-economic 
burden [1], [2], [3]. TBI caused by direct external 
mechanical force to the cranium and its intracranial 
components, causing disruption to the brain structure 
and function, which can be temporary or permanent [4]. 
There are two pathologic processes that occur in 
TBI [5]. The first is primary brain injury, which caused by 
mechanical force exposure to the brain tissue, causing 
axonal, glial cells, and vascular damages of the brain 
tissue [5], [6]. Those damaged brain cells then can 
initiate the second pathologic process in TBI by releasing 
various inflammatory factors and neurotransmitters that 
can initiate and develop the inflammatory cascade, 
thus causing neuroinflammation and aggravate the 
brain injury, which called secondary brain injury 
(SBI) [6], [7], [8], [9], [10], [11], [12], [13], [14]. This SBI 
can lead to more severe morbidities such as motoric, 
cognitive, and psychological disturbances that can be 
suffered by the patients for the rest of their lives, or even 
death [6], [15], [16]. Thus, an inflammatory biomarker 
that can reflect the neuroinflammation and SBI severity 
post-TBI is needed to increase the effectivity of TBI 
patient management and prevent the morbidity and 
mortality caused by SBI post-TBI.
The levels of inflammatory reactions that 
occur in the body can be reflected from increased 
inflammatory cell count, such as neutrophils and 
platelets, or increased inflammatory biomarker levels, 
such as C-reactive protein (CRP) and erythrocyte 
sedimentation rate (ESR) [17], [18]. CRP and ESR are 
commonly used by medical practitioners to help them 
in monitoring the progression of inflammatory diseases. 
However, CRP and ESR are barely used in traumatic 
cases, especially in SBI post-TBI. In addition, CRP 
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and ESR examinations are not always available and 
affordable in every hospital, especially in rural areas.
On the other hand, recent studies showed 
that neutrophil-to-lymphocyte ratio (NLR) and 
platelet-to-lymphocyte ratio (PLR) could act as a 
promising inflammatory biomarker and very easy to be 
measured [18], [19], [20], [21], [22], [23]. NLR and PLR 
can be obtained from the complete blood count (CBC) 
examination, which is more routinely done compared 
to CRP and ESR in traumatic case management, 
especially TBI. The CBC examination also more 
available and affordable in every hospital, including 
in primary health care in rural areas [24]. The CBC 
examination is a simple laboratory test and can provide 
several important data at once about the markers that 
can be useful in daily medical practice. Thus, the CBC 
is recommended to be done before carrying out other 
laboratory tests that are more expensive and invasive 
[25], [26].
NLR and PLR have the potential to be used 
as a marker of the SBI severity post-TBI [18], [19], [20], 
[21], [22], [23], [24], [27], [28], [29], [30], [31], [32], [33]. 
Nevertheless, the TBI patients NLR and PLR results in 
daily medical practice are not yet completely utilized. 
Therefore, this study was conducted to correlate the 
NLR and PLR results with the CRP and ESR results of 
TBI patients as the marker of the inflammatory process 
and SBI severity post-TBI. It is hoped that NLR and PLR 
can become a useful and more affordable marker for 
predicting the severity of inflammatory processes and 
SBI post-TBI. Thus, more effective SBI monitoring to 
alert and prevent the clinical deterioration, morbidities, 
and mortality of TBI patients can be done.
Methods
This cross-sectional study was conducted at 
Sanglah Hospital Denpasar from January to April 2020 
to correlate the NLR and PLR results with the CRP 
and ESR results of TBI patients as the marker of the 
inflammatory process and SBI severity post-TBI. This 
study has been approved and permitted by the Ethical 
Committee of Fakultas Kedokteran Universitas Udayana 
– Sanglah Hospital Denpasar and the Clinical Research 
Unit of Sanglah Hospital Denpasar. This study used all 
of the TBI patient’s medical record that hospitalized 
in Sanglah Hospital Denpasar from January to April 
2020 and used the consecutive sampling technique 
for the patient selection. The inclusion criteria were: 
(1) Diagnosed with TBI; and (2) aged 18 to 65 years old. 
The patients with: (1) History of autoimmune diseases 
such as systemic lupus erythematosus, multiple 
sclerosis, myasthenia gravis, and Guillain–Barre 
syndrome; (2) history of routine immunosuppressant 
drugs consumption, such as dexamethasone and 
methylprednisolone; and (3) multiple bone fractures 
on the extremities that accompanied the TBI were 
excluded from the study.
Variables obtained from the TBI patient’s 
medical record were age, sex, mechanism of injury, 
Glasgow coma scale (GCS) on admission, unconscious 
duration after TBI, history of memory loss after TBI, and 
the laboratory results of NLR, PLR, CRP, and ESR at 
24-h post-TBI. The 5cc of TBI patient’s blood sample 
was obtained at 24-h post-TBI. Then, the 3cc of the blood 
sample was inserted into the ethylenediaminetetraacetic 
acid anticoagulant tube (purple) for CBC and ESR 
laboratory examination, and the other 2cc of the blood 
sample was inserted into the coagulant separating gel 
tube (yellow) for CRP laboratory examination.
The CBC was measured through the flow 
cytometry method using the CELL-DYN Ruby tool 
manufactured by Abbott Laboratories, Illinois – USA. 
Then, the NLR and PLR were calculated by dividing the 
neutrophils count (for NLR) and platelets count (for PLR) 
with the lymphocytes count that obtained from the TBI 
patient’s CBC result. The CRP was measured through 
the immunoturbidimetry method using the CRP Latex 
Cobas 601 tool manufactured by Roche Diagnostics, 
Mannheim – Germany. The ESR was measured using 
the Caretium XC-A30 ESR Analyzer tool manufactured 
by Caretium Medical Instruments Co Ltd, Shenzhen 
– China.
The collected data were analyzed using the 
SPSS Statistics 23 application. A descriptive analysis 
test was done to obtain the result of the characteristics 
of TBI patients involved in this study. Then, the results 
were described with mean ± standard deviation (SD) 
or median ± interquartile range (IQR) and frequency. 
The Kolmogorov–Smirnov test was done to obtain 
the normality of the data distribution. Finally, the 
nonparametric Spearman’s rho correlation test was 
done to obtain the correlation between the NLR and 
PLR with the CRP and ESR in TBI patients. The values 
of the correlation between these variables were stated 
in the correlation coefficient (r) and p-value. A significant 
correlation is achieved if *p < 0.05 in the data analysis 
result.
Results
A total of 85 samples were met the sampling 
criteria, and their data were obtained in this study. 
The sample characteristics are shown in Table 1. The 
minimum and maximum age obtained from this study 
were 18-year-old and 64-year-old consecutively, with 
mean ± (SD) 38.89 ± (15.27)-year-old and median ± 
(IQR) 39 ± (29.5)-year-old. Moreover, the TBI cases in 
this study were dominated by the 20–29-year-old age 
group (Figure 1). In this study, men (77.6%) were more 
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dominant to had TBI compared to women (22.4%). 
Traffic accident (84.7%) was the leading cause of 
TBI, followed by fall (14.1%) and assault (1.2%) 
consecutively.
Figure 1: Bar chart of the traumatic brain injury cases age group 
frequency
The minimum and maximum GCS on 
admission score obtained from this study were three 
and 15 consecutively, with mean ± (SD) 11.45 ± (3.45), 
and median ± (IQR) 12 ± (5). The proportion of samples 
who had a severe, moderate, and mild head injury were 
11.8%, 45.9%, and 42.3% consecutively. Based on the 
unconscious duration, as many as 47.1%, 35.3%, and 
17.6% of the samples had unconscious duration for 
<30-min, 30-min to 24-h, and >24-h consecutively. As 
many as 22.4% of the samples had a history of memory 
loss after TBI, while the other 77.6% of the samples had 
no history of memory loss after TBI.
The minimum and maximum neutrophils count 
obtained from this study were 3.82 × 103/μL and 20.40 
× 103/μL consecutively, with mean ± (SD) 10.84 ± 
(3.87) × 103/μL, and median ± (IQR) 10.36 ± (5.02) × 
103/μL. As many as 81.2% of the TBI patients had 
neutrophilia (neutrophils count >7.5 × 103/μL), while 
the other 18.8% were within the normal range. The 
minimum and maximum lymphocytes count obtained 
from this study were 0.48 × 103/μL and 3.74 × 103/μL 
consecutively, with mean ± (SD) 1.49 ± (0.65) × 103/μL 
and median ± (IQR) 1.33 ± (0.98) × 103/μL. There were 
only 28.2% of the TBI patients who had lymphopenia 
(lymphocytes count <1 × 103/μL), while the other 
71.8% were within the normal range. The minimum and 
maximum platelets count obtained from this study were 
92.30 × 103/μL and 330.10 × 103/μL, with mean ± (SD) 
203.75 ± (60.70) × 103/μL, and median ± (IQR) 202 ± 
(86.2) × 103/μL. As many as 22.4% of the TBI patients 
had thrombocytopenia (platelets count <150 × 103/μL), 
while the other 77.6% were within the normal range.
The minimum and maximum NLR obtained from 
this study were 1.87 and 33.44, with mean ± (SD) 9.21 ± 
(6.42), and median ± (IQR) 7.60 ± (6.83). The minimum 
and maximum PLR obtained from this study were 54.22 
and 366.03, with mean ± (SD) 153.77 ± (62.57), and 
median ± (IQR) 145.58 ± (76.95). The minimum and 
maximum CRP obtained from this study were 3.54 mg/L 
and 271.90 mg/L, with mean ± (SD) 73.79 ± (52.34) mg/L 
and median ± (IQR) 60.83 ± (66.3) mg/L. As many as 
97.6% of the TBI patients had elevated CRP levels (CRP 
>5 mg/L), while the other 2.4% were within the normal 
range. The minimum and maximum ESR obtained from 
this study were 1.6 mm/h and 84.3 mm/h, with mean ± 
(SD) 16.76 ± (14.42) mm/h, and median ± (IQR) 12.50 ± 
(13.85) mm/h. As many as 28.2% of the TBI patients had 
elevated ESR levels (ESR >20 mm/h), while the other 
71.8% were within the normal range.
The Kolmogorov–Smirnov test results are 
shown in Table 2. The results of the NLR, PLR, CRP, 
and ESR variables were *p < 0.05, which means 
that the data were not normally distributed. Thus, the 
correlation test used is the nonparametric Spearman’s 
rho correlation test. The nonparametric Spearman’s 
rho correlation test results are shown in Table 3. NLR 
Table 1: The characteristics of TBI patients
Variable Frequency (%)/mean ± (SD)/median ± (IQR)
Age (years old) 39 ± (29.5)
Sex
Men 66 (77.6)
Women 19 (22.4)
Mechanism of injury
Traffic accident 72 (84.7)
Fall 12 (14.1)
Assault 1 (1.2)
GCS on admission 12 ± (5)
Head injury severity
Severe 10 (11.8)
Moderate 39 (45.9)
Mild 36 (42.3)
Unconscious duration
>24-h 15 (17.6)
30-min to 24-h 30 (35.3)
<30 min 40 (47.1)
Memory loss
Yes 19 (22.4)
No 66 (77.6)
Neutrophils count 10,84 ± (3.87)
Neutrophilia
Yes 69 (81.2)
No 16 (18.8)
Lymphocytes count 1,33 ± (0.98)
Lymphopenia
Yes 24 (28.2)
No 61 (71.8)
Platelets count 203,75 ± (60.70)
Thrombocytopenia
Yes 19 (22.4)
No 66 (77.6)
NLR 7.60 ± (6.83)
PLR 145.58 ± (76.95)
CRP 60.83 ± (66.3)
ESR 12.50 ± (13.85)
SD: Standard deviation, IQR: Interquartile range, GCS: Glasgow coma scale, NLR: Neutrophil-
to-lymphocyte ratio, PLR: Platelet-to-lymphocyte ratio, CRP: C-reactive protein, ESR: Erythrocyte 
sedimentation rate. Mean ± (SD): Neutrophils count, platelet count, Median ± (IQR): Age, GCS on 
admission, lymphocytes count, NLR, PLR, CRP, ESR.
Table 2: The NLR, PLR, CRP, and ESR variable’s Kolmogorov–
Smirnov test results
Variable Sig. (p-value)
NLR 0.001
PLR 0.036
CRP 0.010
ESR 0.000
NLR: Neutrophil-to-lymphocyte ratio, PLR: Platelet-to-lymphocyte ratio, CRP: C-reactive protein, 
ESR: Erythrocyte sedimentation rate
Table 3: The nonparametric Spearman’s rho correlation test 
results
Variable CRP ESR
NLR
r 0.472** 0.047
p-value 0.000 0.668
PLR
r 0.283** 0.069
p-value 0.009 0.533
**Correlation is significant at the 0.01 level (2-tailed), r: Correlation coefficient, NLR: Neutrophil-to-lymphocyte 
ratio, PLR: Platelet-to-lymphocyte ratio, CRP: C-reactive protein, ESR: Erythrocyte sedimentation rate.
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and PLR had a significant positive correlation with 
CRP (r = 0.472, **p < 0.01; and r = 0.283, **p < 0.01 
consecutively) in TBI patients. While NLR and PLR 
were not correlated with ESR (r = 0.047, p > 0.05; and 
r = 0.069, p > 0.05 consecutively) in TBI patients.
Discussion
Samples characteristics
Based on the age variable, the result of this 
study had supported several previous studies, which 
found that the average age of the TBI patients was 
32–41-year-old, and TBI is one of the leading cause 
of morbidity and mortality in individuals under 45-year-
old [2], [34], [35]. The result of this study also supported 
the previous study, which found that TBI patients in the 
21–30-year-old age group had the largest number of 
TBI cases compared to other age groups [36].
This study found that men were more likely 
to had a TBI compared to women. It supported 
several previous studies, which found that men 
had a bigger proportion compared to women 
in experiencing TBI, reaching 77–88% of TBI 
cases [29], [30], [34], [35], [36], [37]. The high incidence 
of TBI in men can be due to the fact that men are more 
dominant in doing high-risk activities, experiencing 
work-related accidents, and experiencing assault-
related injuries compared to women [38].
This study found that traffic accident was the 
leading mechanism of injury that could cause TBI, 
followed by fall and assault consecutively. It supported 
several previous studies which also found that traffic 
accident was the highest mechanism of injury that 
could cause TBI, then followed by fall and other causes, 
such as assault [29], [34], [35], [36]. Therefore, young 
adult men must be more vigilant in carrying out high-
risk activities to prevent TBI. Moreover, preventive 
measures such as providing education about safety 
riding and increasing awareness in driving can also be 
useful to prevent TBI due to traffic accidents.
This study found that there was an elevated 
mean neutrophils count in TBI patients, and most of 
the TBI patients had neutrophilia (neutrophils count 
>7.5 × 103/μL). These results supported several previous 
studies, which also found that there was increased 
neutrophils count in TBI patients [28], [30]. Neutrophils 
can be modulated by various endogenous factors such 
as granulocyte-colony stimulating factor (G-CSF) and 
granulocyte-macrophage-CSF (GM-CSF) [39], as well 
as external stimuli, such as stress and trauma, including 
TBI [40], [41]. Neutrophils can be activated by several 
cytokines, such as tumor necrosis factor-α (TNF-α), 
interleukin (IL) IL-1β, IL-6, GM-CSF, C-X-C chemokine 
ligand (CXCL) CXCL1-5, and CXCL8-10 that released 
by damaged glial cells after TBI [7], [8], [9], [14]. These 
activated neutrophils can initiate the inflammatory 
cascade and develop neuroinflammation, thus increased 
brain tissue damage and SBI post-TBI [2], [6].
This study found that the mean lymphocytes 
count in TBI patients was within the normal range and 
only 28.2% of them who had lymphopenia (lymphocytes 
count <1 × 103/μL). These results could happen because 
the CBC examination in this study was carried out on 
the 1st-day post-TBI. The most significant decrease 
in lymphocytes count usually occurs on the 3rd-day 
post-TBI, and then it will return to the normal range 
on the 7–14th-day post-TBI [42], [43]. The decreased 
lymphocytes count in TBI patients can occur due to 
increased release of cortisol hormone by the adrenal 
glands in response to TBI stress [42], [44], [45].
Cortisol can reduce the lymphocytes count 
by suppressing lymphocyte’s mobility and migration, 
thereby inhibiting the lymphocytes release into the 
circulation [45]. The higher the stress level or TBI 
severity, the higher the cortisol level, so the lower the 
lymphocytes count. Conversely, a higher lymphocytes 
count represents a more precise immune response 
and a more stable inflammatory pathway [44], [46]. The 
result of this study supported the previous study, which 
found that the plasma cortisol level did not change 
significantly on the 1st-day post-TBI, so they did not have 
a significant impact on the lymphocytes count [43]. The 
low number of samples who had lymphopenia in this 
study could also be due to only 11.8% of the samples 
that had a severe head injury, where the most significant 
reduction in lymphocytes count occurred in the group of 
patients with severe head injury [42], [43].
This study found that the mean platelets 
count in TBI patients was within the normal range, 
and none of them had thrombocytosis. Some of TBI 
patients had thrombocytopenia instead. These results 
supported several previous studies, which also found 
that the platelet count of TBI patients was still within the 
normal range [47], [48]. The decreased platelets count 
in TBI patients can occur due to the increased platelet 
consumption (consumption coagulopathy), where the 
coagulation system will be activated when the blood 
passes through the injured brain tissue post-TBI [47]. 
The brain vasculature has large deposits of tissue 
factor (TF), which play an important role in inducing 
the central nervous system and systemic coagulopathy 
post-TBI [49], [50]. TF is an essential initiator protein 
of the coagulation cascade and present in endothelial 
cells and leukocytes. TF will be released into the blood 
circulation after an injury to the brain vasculature [50].
This study found that there was an elevated 
mean CRP level in TBI patients, and most of the TBI 
patients had elevated CRP levels (CRP >5 mg/L). These 
results supported several previous studies, which also 
found that there were increased CRP levels in most of the 
TBI patients [51], [52], [53], [54]. This could occur because 
CRP is an acute-phase reactant that can be used to 
 Kusuma et al. NLR and PLR Correlations with CRP and ESR in TBI
Open Access Maced J Med Sci. 2020 Dec 01; 8(B):1185-1192. 1189
identify and monitor the neuroinflammatory processes 
in SBI post-TBI [53], [55]. The increase in CRP levels is 
commensurate with the increase in inflammatory mediators 
(cytokines) produced by cells that actively participate 
in the neuroinflammatory processes post-TBI, such as 
IL-1, IL-6, TNF-α, and transforming growth factor-β [56]. 
The benefit of CRP over other non-specific inflammatory 
markers (such as ESR) is its ability to respond rapidly to 
inflammatory processes in the body [55]. Therefore, CRP 
can be useful in the assessment of severity, metabolic 
response, prediction of clinical outcomes, and monitoring 
of response in TBI patients [53].
This study found that the mean ESR 
levels in TBI patients were within the normal range, 
and only 28.2% of them had elevated ESR levels 
(ESR >20 mm/h). These results could occur because 
the ESR examinations were carried out on the 1st-day 
post-TBI, where the ESR levels did not change rapidly 
at the beginning of the inflammatory process and would 
return to normal range in a longer time than other acute 
phase reactants [57]. This is also supported by previous 
research on TBI cases, which found that the results of 
ESR examination performed at 1-year follow-up post-
TBI were significantly increased, compared to the 
control group, with mean ESR levels 24.6 ± 3.7 mm/h 
and 11.7 ± 2.6 mm/h for TBI group and control group 
consecutively [58].
Correlation of NLR and PLR with CRP and 
ESR in TBI patients
This study found that NLR and PLR were 
positively correlated with CRP in TBI patients. This 
could occur because the neuron and glial cells 
damaged by TBI can release various inflammatory 
cytokines and neurotransmitters, such as IL-1β, TNF-
α, IL-6, CXCL1-5, CXCL8-10, and GM-CSF to induce 
the inflammatory cascade response and develop 
neuroinflammation. These inflammatory cytokines 
can cause neutrophils and platelets activation, 
increase thrombopoiesis, and increase the CRP 
levels [6], [8], [9], [11], [56], [59], [60].
NLR is a reflection of inflammatory response 
levels (neutrophils) and immune status (lymphocytes), 
which indicates an increased release of inflammatory 
cytokines when its levels were increased [19], [20]. 
Neutrophils are recruited into the injury site within 
1-h post-TBI and can release inflammatory cytokines 
that can exacerbate SBI and induce neuronal 
death [61], [62]. The increased neutrophils count can 
increase the blood-brain barrier (BBB) damage, brain 
tissue damage, and neuronal death, which results in 
increased inflammatory reactions and worsens the brain 
tissue damage [63]. Platelets also play an active role 
in the inflammatory process [18]. Platelets can induce 
the release of inflammatory cytokines and interact with 
various cells, including neutrophils, T-lymphocytes, 
and macrophages, which will have an impact on the 
initiation and exacerbation of neuroinflammation 
and SBI [22], [32], [33]. The increase of NLR and 
PLR levels indicate increased cellular damage, BBB 
damages, neuroinflammation process, and cerebral 
edema, thus reflecting a more severe SBI post-TBI [64]. 
Furthermore, CRP levels are doubled every 8-h and 
peak within 36–50-h after the onset of TBI [65]. Since 
the NLR, PLR, and CRP are increased rapidly post-TBI 
so that the NLR and PLR results on the 1st-day post-TBI 
can have a positive correlation with CRP results on the 
1st-day post-TBI in TBI patients.
This study found that NLR and PLR were not 
correlated with ESR in TBI patients. This could occur 
because the CBC and ESR examinations were carried 
out on the 1st-day post-TBI, where the ESR levels do 
not change rapidly at the beginning of the inflammatory 
process and return to normal range in a longer time than 
other acute phase reactants, while NLR levels can increase 
rapidly post-TBI, and PLR levels also have not increased 
significantly [2], [22], [42], [43], [57], [61], [62]. ESR begins 
to increase within 24–48-h after the onset of inflammation 
(slower than CRP), then gradually decreases after the 
inflammation subsides. Therefore, ESR is considered 
as a better marker for clinical monitoring over the course 
of the disease over time and for chronic inflammatory 
diseases [65], [66]. Maybe it would be better if the blood 
examinations were carried out on the 3rd-day post-TBI to 
assess the correlation between NLR and PLR with ESR 
in TBI patients, where the ESR levels had already begun 
to increase, and the lymphocytes count would experience 
a more significant decrease so that it could affect the PLR 
results in TBI patients [22], [42], [43].
Conclusion
This research proved that NLR and PLR were 
positively correlated with CRP in TBI patients, but NLR 
and PLR were not correlated with ESR in TBI patients. 
Therefore, the NLR and PLR can be considered as a 
useful and more affordable marker of acute inflammation 
to assess the severity of neuroinflammation and 
SBI post-TBI in daily medical practice. Thus, a more 
effective SBI monitoring using the NLR and PLR to alert 
and prevent the clinical deterioration, morbidities, and 
mortality of TBI patients can be done.
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